
Hiv vaccine design and the neutralizing antibody problem
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:

Eliciting broadly neutralizing antibodies to human immunodeficiency virus could bring closer the goal of a successful AIDS vaccine. Here the International AIDS Vaccine Initiative
Neutralizing Antibody Consortium discusses current approaches to overcome the problems faced. Access through your institution Buy or subscribe This is a preview of subscription content,
access via your institution RELEVANT ARTICLES Open Access articles citing this article. * IDIOTYPE/ANTI-IDIOTYPE ANTIBODIES: AS A GLORIOUS SAVIOR IN COVID-19 PANDEMICS * Ahsan Naveed * ,
Deeba Naz * & Sajjad ur Rahman _Translational Medicine Communications_ Open Access 23 August 2021 * HIV-1 SUBVERTS THE COMPLEMENT SYSTEM IN SEMEN TO ENHANCE VIRAL TRANSMISSION *
Bernadien M. Nijmeijer * , Marta Bermejo-Jambrina * … Teunis B.H. Geijtenbeek _Mucosal Immunology_ Open Access 10 February 2021 * MOLECULAR RECOGNITION OF THE NATIVE HIV-1 MPER REVEALED BY
STED MICROSCOPY OF SINGLE VIRIONS * Pablo Carravilla * , Jakub Chojnacki * … José L. Nieva _Nature Communications_ Open Access 08 January 2019 ACCESS OPTIONS Access through your institution
Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full
article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs *
Contact customer support REFERENCES * Wyatt, R. & Sodroski, J. _Science_ 280, 1884–1888 (1998). Article CAS Google Scholar * Parren, P.W. & Burton, D.R. _Adv. Immunol._ 77,
195–262 (2001). Article CAS Google Scholar * Johnson, W.E. & Desrosiers, R.C. _Annu. Rev. Med._ 53, 499–518 (2002). Article CAS Google Scholar * Saphire, E.O. et al. _Science_ 293,
1155–1159 (2001). Article CAS Google Scholar * Calarese, D.A. et al. _Science_ 300, 2065–2071 (2003). Article CAS Google Scholar * Zwick, M.B. et al. _J. Virol._ 75, 10892–10905
(2001). Article CAS Google Scholar * Stanfield, R.L., Gorny, M.K., Williams, C., Zolla-Pazner, S. & Wilson, I.A. _Structure_ (in the press). * Sharon, M. et al. _Structure (Camb)_ 11,
225–236 (2003). Article CAS Google Scholar * Proudfoot, A.E. et al. _J. Biol. Chem._ 276, 10620–10626 (2001). Article CAS Google Scholar * Labrijn, A.F. et al. _J. Virol._ 77,
10557–10565 (2003). Article CAS Google Scholar * Choe, H. et al. _Cell_ 114, 161–170 (2003). Article CAS Google Scholar * Golding, H. et al. _J. Virol._ 76, 6780–6790 (2002). Article
CAS Google Scholar * Sanders, R.W. et al. _J. Virol._ 76, 8875–8889 (2002). Article CAS Google Scholar * Yang, X., Wyatt, R. & Sodroski, J. _J. Virol._ 75, 1165–1171 (2001). Article
CAS Google Scholar * Grundner, C., Mirzabekov, T., Sodroski, J. & Wyatt, R. _J. Virol._ 76, 3511–3521 (2002). Article CAS Google Scholar * Srivastava, I.K. et al. _J. Virol._ 77,
11244–11259 (2003). Article CAS Google Scholar * Pantophlet, R., Wilson, I.A. & Burton, D.R. _J. Virol._ 77, 5889–5901 (2003). Article CAS Google Scholar * Fouts, T. et al. _Proc.
Natl. Acad. Sci. USA_ 99, 11842–11847 (2002). Article CAS Google Scholar * Klausner, R.D. et al. _Science_ 300, 2036–2039 (2003). Article CAS Google Scholar * Kwong, P.D., Wyatt, R.,
Sattentau, Q.J., Sodroski, J. & Hendrickson, W.A. _J. Virol._ 74, 1961–1972 (2000). Article CAS Google Scholar * Selvarajah, S. & Burton, D.R. _Accelerating AIDS Vaccine
Development: Challenges and Opportunities_ (eds. Kahn, P., Gust, P. & Koff, W.) (Horizon Scientific Press, Norwich, UK, in the press). Download references AUTHOR INFORMATION AUTHORS AND
AFFILIATIONS * Departments of Immunology and Molecular Biology, Scripps Research Institute, La Jolla, California, USA Dennis R Burton * Division of Microbiology, New England Regional Primate
Research Center, Harvard Medical School, Southborough, Massachusetts, USA Ronald C Desrosiers * Department of Pathology, University of Pennsylvania, Philadelphia, Pennsylvania, USA Robert W
Doms * International AIDS Vaccine Initiative, New York, New York, USA Wayne C Koff * Vaccine Research Center, National Institutes of Health, Bethesda, Maryland, USA Peter D Kwong, Gary J
Nabel & Richard T Wyatt * Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York, USA John P Moore * Department of Cancer Immunology
and AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA Joseph Sodroski * Department of Molecular Biology and the Skaggs Institute for Chemical Biology,
Scripps Research Institute, La Jolla, California, USA Ian A Wilson Authors * Dennis R Burton View author publications You can also search for this author inPubMed Google Scholar * Ronald C
Desrosiers View author publications You can also search for this author inPubMed Google Scholar * Robert W Doms View author publications You can also search for this author inPubMed Google
Scholar * Wayne C Koff View author publications You can also search for this author inPubMed Google Scholar * Peter D Kwong View author publications You can also search for this author
inPubMed Google Scholar * John P Moore View author publications You can also search for this author inPubMed Google Scholar * Gary J Nabel View author publications You can also search for
this author inPubMed Google Scholar * Joseph Sodroski View author publications You can also search for this author inPubMed Google Scholar * Ian A Wilson View author publications You can
also search for this author inPubMed Google Scholar * Richard T Wyatt View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHORS
Correspondence to Dennis R Burton or John P Moore. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Burton, D., Desrosiers, R., Doms, R. _et al._ HIV
vaccine design and the neutralizing antibody problem. _Nat Immunol_ 5, 233–236 (2004). https://doi.org/10.1038/ni0304-233 Download citation * Issue Date: 01 March 2004 * DOI:
https://doi.org/10.1038/ni0304-233 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently
available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative